|
Parameter
|
Total
|
|---|
|
Sex (f/m)
|
63/42
|
|
Age
|
79 (75, 82)
|
|
BMI
|
27.7 (24.7, 30.8)
|
|
Cardiovascular Risk Factors
|
|
Hypertension
|
93
|
|
Diabetes
|
37
|
|
Dyslipidaemia
|
64
|
|
Active smoking
|
8
|
|
Atrial fibrillation
|
16
|
|
Cardiovascular magnetic resonance
|
|
LV EDVI (ml/m2)
|
79 (65, 98)
|
|
LV ESVI (ml/m2)
|
31 (18, 45)
|
|
LV EF (%)
|
60.5 (47.4, 72.0)
|
|
LV Mass (g/m2)
|
85 (69, 105)
|
|
LGE (g)
|
26.1 (14.7, 45.8)
|
|
NYHA
|
|
I, II, III, IV
|
6, 35, 60, 4
|
|
Laboratory Testing
|
|
NTproBNP (pg/ml)
|
1452 (608, 3916)
|
|
Creatinine (mg/dl)
|
1.03 (0.86, 1.19)
|
|
eGFR (ml/min/1.73m2)
|
60.0 (50.4, 75.3)
|
|
Echocardiography
|
|
Peak aortic valve velocity (m/s)
|
4.0 (3.6, 4.6)
|
|
Mean Gradient (mmHg)
|
38 (29, 53)
|
|
Aortic valve area (cm2)
|
0.8 (0.6, 0.9)
|
- Values are reported given as median and interquartile range or absolute numbers and associated percentage as appropriate.
- LV left ventricular, EDVI/ESVI end-diastolic/systolic volume index, EF ejection fraction, eGFR estimated glomerular filtration rate; LGE late gadolinium enhancement; NYHA New York Heart Association; BMI body mass index
